HomeINMB • NASDAQ
add
INmune Bio Inc
Previous close
$2.14
Day range
$2.01 - $2.19
Year range
$1.38 - $11.64
Market cap
53.44M USD
Avg Volume
472.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.43M | -39.50% |
Net income | -6.47M | 46.48% |
Net profit margin | — | — |
Earnings per share | -0.24 | 60.00% |
EBITDA | -7.42M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 27.73M | -17.34% |
Total assets | 33.36M | -36.80% |
Total liabilities | 7.98M | -43.43% |
Total equity | 25.38M | — |
Shares outstanding | 26.59M | — |
Price to book | 2.25 | — |
Return on assets | -52.31% | — |
Return on capital | -66.63% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -6.47M | 46.48% |
Cash from operations | -5.44M | 22.14% |
Cash from investing | -193.00K | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -5.64M | -327.14% |
Free cash flow | -3.57M | -34.34% |
About
Founded
2015
Headquarters
Website
Employees
18
